Overall survival in the OlympiA trial

Overall survival in the OlympiA trial

OVERVIEW OlympiA demonstrates statistically significant improvement in overall survival with adjuvant olaparib compared with placebo TITLE OF PUBLICATION Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants...
EPoS

EPoS

The EPoS (European Polyp Surveillance) study is a group of related randomised controlled clinical trials which aim to address the optimum colonoscopy surveillance interval for patients who have had premalignant polyps identified and removed from the large bowel, in...
NordICC

NordICC

Learn how Frontier science scotland partnered with the University of Oslo for the nordicc study In collaboration with the University of Oslo, FSS held responsibility for trial data collection, management and cleaning processes. After inheriting the original Case...